Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Micromed AS
AS
Active
Org 973191578
Vollsveien 13H, 3. Etasje, 1366
Lysaker
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1994 · 31 years old
5 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Micromed AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
59M
44M
29M
15M
0M
2021: 27M
27M
2021
2022: 25M (-7% vs 2021)
25M
-7%
2022
2023: 34M (+36% vs 2022)
34M
+36%
2023
2024: 41M (+21% vs 2023)
41M
+21%
2024
2025: 47M (+15% vs 2024)
47M
+15%
2025
EBITDA
NOK millions
15M
10M
5M
0M
-5M
2021: 0M
0M
2021
2022: -1M
-1M
2022
2023: 0M (+100% vs 2022)
0M
+100%
2023
2024: 3M
3M
2024
2025: 11M (+267% vs 2024)
11M
+267%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
47 262
40 956
34 320
25 290
26 927
Staff expenses
−3 049
−3 576
−3 743
−3 950
−3 943
EBITDA
10 761
2 586
459
−866
324
Depreciation & amort.
−13
−68
−116
−184
−184
EBIT
10 748
2 518
342
−1 050
140
Net financials
−245
672
−35
1
−1 099
Profit before tax
10 503
3 190
308
−1 050
−959
Tax
2 360
462
−0
−38
45
Net profit
8 143
2 729
308
−1 012
−1 004
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
28 814
17 323
12 207
10 478
10 706
Equity
11 656
6 013
3 285
2 977
3 989
Long-term debt
29
0
0
0
38
Short-term debt
17 128
11 310
8 922
7 501
6 680
Total debt
17 158
11 310
8 922
7 501
6 718
Financial ratios
5-year trend
EBITDA margin
22,8 %
This company
15,8 %
Market median
This company
Market median
44% above market
2021
2025
Equity ratio
40,5 %
This company
38,2 %
Market median
This company
Market median
6% above market
2021
2025
Return on equity
69,9 %
This company
18,4 %
Market median
This company
Market median
280% above market
2021
2025
Net profit margin
17,2 %
This company
8,1 %
Market median
This company
Market median
112% above market
2021
2025
Asset turnover
1,64×
This company
1,12×
Market median
This company
Market median
46% above market
2021
2025
Debt / equity
1,47×
This company
0,62×
Market median
This company
Market median
137% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Micromed AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
